![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 34, 26404-26410, August 25, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,From the Centro de Biología Molecular "Severo Ochoa" (Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid), Universidad Autónoma, Canto Blanco, 28049 Madrid, Spain
Received for publication, March 31, 2000, and in revised form, May 23, 2000
| |
ABSTRACT |
|---|
|
|
|---|
Protein p6 of Bacillus subtilis phage
Ø29 is involved in the initiation of viral DNA replication and
transcription by forming a multimeric nucleoprotein complex with the
phage DNA. Based on this, together with its abundance and its capacity
to bind to the whole viral genome, it has been proposed to be a viral
histone-like protein. Protein p6 is in a monomer-dimer-oligomer
equilibrium association. We have identified protein p6 mutants
deficient in self-association by testing random mutants obtained by
degenerated polymerase chain reaction in an in vivo assay
for dimer formation. The mutations were mainly clustered in two regions
located at the N terminus, and the central part of the protein.
Site-directed single mutants, corresponding to those found in
vivo, have been constructed and purified. Mutant p6A44V, located
at the central part of the protein, showed an impaired dimer formation
ability, and a reduced capacity to bind DNA and to activate the
initiation of Ø29 DNA replication. Mutant p6I8T has at least 10-fold
reduced self-association capacity, does not bind DNA nor activate Ø29 DNA initiation of replication. C-terminal deletion mutants showed an
enhanced dimer formation capacity. The highly acidic tail, removed in
these mutants, is proposed to modulate the protein p6
self-association.
DNA transactions, such as DNA replication and transcription,
require higher-order DNA-protein complexes, the assembly of which is
sometimes facilitated by proteins with an architectural function. This
is the case of the nucleoid-associated proteins, of which the ones most
extensively studied are HU, H-NS, IHF, and FIS. They all bind and bend
DNA, sharing some common characteristics such as being very abundant,
having a small size, and playing a pleiotropic role. The function of
these proteins requires formation of dimers or oligomers. Thus, HU is a
homodimer in most bacteria, although it is a heterodimer in
Escherichia coli (1, 2), IHF is a heterodimeric protein
encoded by two genes, himA (3) and hip (4), and
FIS is a homodimer (5, 6). On the other hand, H-NS monomers undergo
self-association to form tetramers (7). The N-terminal domain of H-NS
is involved in oligomerization (8, 9), and the oligomeric structure of
H-NS is necessary for recognition of intrinsically curved DNA and
bending (10).
Protein p6 of Bacillus subtilis phage Ø29 is required
in vivo for viral genome replication (11, 12) and repression
of transcription from the early promoter C2 (13). In vitro
studies have shown that protein p6 is involved both in replication and transcription; it stimulates the initiation and the transition to
elongation steps of Ø29 DNA replication (14, 15), represses the early
C2 promoter (16), and regulates the switch between early and late
transcription (17). These functions are accomplished by the formation
of a nucleoprotein complex in which the DNA adopts a right-handed
toroidal conformation, and thus wrapping around a multimeric protein p6
core (18).
The number of copies of protein p6 in B. subtilis cells at
late times of Ø29 infection has been calculated to be 6.6 × 105, enough to bind the entire viral progeny DNA (19).
This, together with the ability to bind in vitro to the
whole Ø29 genome, led us to propose a structural role in compacting
and organizing the viral genome (20). The amounts of other histone-like
proteins are cell cycle-dependent; thus, for E. coli cells in logarithmic growth, the most abundant ones are FIS
and HU, with 1.2 × 104 and 1.5 × 105 copies per cell, respectively, whereas at stationary
phase the most abundant is IHF with 1.2 × 104 copies
per cell (21). With these amounts, only a minor part of the bacterial
genome would be bound by these proteins. Sedimentation equilibrium
studies have shown that protein p6 is in a monomer-dimer equilibrium
that shifts to higher association states at the millimolar concentrations found in vivo (19). These oligomeric
structures have been observed by transmission electron microscopy (22), and their structure, as deduced by image processing, is compatible with
that described for the path followed by the DNA in the protein p6·DNA complex (18). Thus, it has been proposed that protein p6 could act as a scaffold organizing the DNA into the appropriate configuration. Protein p6 binding to DNA is highly
cooperative1 and extends
throughout the whole Ø29 DNA forming multiple complexes of very
heterogeneous sizes; the minimal size ranges from ~130 base pairs
(bp)2 observed by electron
microscopy after psoralen cross-linking, to ~80-90 bp, shown by
protection of micrococcal nuclease digestion (20). Thus, multiple
protein-DNA and protein-protein interactions are required to stabilize
the complex, suggesting that association equilibria among protein p6
oligomers would modulate their interaction with DNA.
In this work we have searched regions involved in protein p6
self-interaction. The characterization of deletion mutants has suggested that the N-terminal region is involved in protein p6 self-association, and the C-terminal acidic region interferes with it.
We have obtained a collection of protein p6 random mutants unable to
form dimers by using an in vivo self-association assay. The
mutations were mainly clustered in two regions, located at the
N-terminal and central parts of the protein. This allowed us to design
site-directed mutants, which have been tested in vitro. The
results obtained indicate that protein p6 dimer formation is
drastically reduced by mutation I8T, whereas mutation A44V impairs
dimerization and decreases the activation of Ø29 DNA initiation of replication.
Materials--
Isopropyl Construction of Phage Random Mutagenesis in Gene 6--
Random mutagenesis of R6A
single mutant gene 6 was performed on plasmid p Site-directed Mutagenesis in Gene 6--
Site-directed mutants
of wt gene 6 were constructed by PCR using plasmid pPR55w6 (23) as
template. As primers, we have used four oligonucleotides with
degenerated positions, to obtain mutations in amino acids 7, 8, 43, and
44 of protein p6
(5'-CGGTTGTCTTTGTGRTTWCTCTCTGC-3'; 5'-GCAGAGAGWAAYCACAAAGACAACCG-3';
5'-CTCCATTGARCTYGTTCCATTGTC-3'; 5'-GACAATGGAACRAGYTCAATGGAG-3').
Two oligonucleotides 5'-CGACCTGCAGGGATCCGGCC-3' and
5'-CTAATACTAGAAGCTTCTCTTGTG-3' were used to generate
BamHI and HindIII restriction sites to clone the
fragments containing mutated gene 6 into plasmid pPLc28 (28) under the
control of Purification of Protein p6 Deletion Mutants--
Cultures of
E. coli K-12 Purification of Protein p6 Site-directed Mutants--
Cultures
of E. coli K-12 Initiation of DNA Replication Assay--
The reaction mixture
contained (in 25 µl) 50 mM Tris-HCl, pH 7.5; 10 mM MgCl2; 20 mM ammonium sulfate; 1 mM dithiothreitol; 10% glycerol; 0.25 µM
[ Cross-linking with Glutaraldehyde--
Glutaraldehyde
cross-linking was carried out essentially as described (32). Either wt
or mutant p6 proteins, 5 µM each, were incubated at room
temperature in 20 mM triethanolamine, pH 8.0, 50 mM NaCl, and 300 µM glutaraldehyde. After
45-min incubation, the reaction was stopped by adding Tris-HCl, pH 7.5, up to 150 mM. Samples were analyzed by SDS-Tricine-PAGE
(33).
Sedimentation Equilibrium Analysis--
The experiments were
performed in a Beckman Optima XL-A analytical ultracentrifuge equipped
with absorbance optics, using an An60Ti rotor. Protein p6 was
equilibrated in 50 mM Tris-HCl, pH 7.5, 10 mM
MgCl2, and 50 mM NaCl. Protein p6 (100 µl of
100 µM) was centrifuged at 25,000 rpm, and
absorbance scans at 280 nm were taken at sedimentation equilibrium. The
equilibrium temperature was 4 °C. High speed sedimentation (42,000 rpm) was conducted afterward for baseline correction.
Whole cell apparent weight average molecular weights
(Mw,a) were determined by fitting a
sedimentation equilibrium model for a single sedimenting solute to
individual datasets with the program EQASSOC (supplied by Beckman, Ref.
34). The partial specific volume of protein p6 was 0.728 ml/g,
calculated from the amino acid composition of the protein deduced from
the gene 6 sequence (35).
DNase I Footprinting--
DNase I footprinting was carried out
essentially as described (36). The indicated amounts of either wt or
mutant p6 proteins were incubated with 2 ng of Ø29 DNA left terminal
fragment, 259 bp long. The DNA fragment was obtained by PCR in a
reaction containing 0.2 µg of Ø29 DNA as template, 1 µM oligonucleotides
5'-GCGCTTTAAAGTAAGCCCCCACCCTC-3' and
5'-GCCCACATACTTTGTTGATTGG-3', 100 µM dNTP, and 2 units of Vent polymerase in its reaction buffer. The last
oligonucleotide was previously 5'-labeled with
[ Circular Dichroism--
Circular dichroism spectra were recorded
using a Jasco J-720 spectropolarimeter using a 0.2-cm path length
cuvette. Proteins were used at room temperature at a concentration of
0.13 g/l in 10 mM Tris-HCl, pH 7.5. The final spectrum in
each case is the mean of 10 measurements with a step size of 0.2 nm
recorded from 260 to 200 nm. Data were base line-corrected by
substraction of that of the Tris buffer.
Self-association of Protein p6 Deletion Mutants--
It has been
reported that N-terminal deletion mutants of protein p6 lacking 5 or 13 amino acids (p6N Self-interaction of Protein p6 in Vivo--
To further investigate
the protein p6 regions involved in self-association, we carried out an
in vivo assay in which we used the region encoding the
N-terminal domain of
We have used the plasmid pBF21 (10), expressing the Random Mutagenesis of Gene 6 and in Vivo Selection of Protein p6
Mutants Defective in Self-interaction--
The in vivo
assay described above sets up the basis to select mutants in
self-association. Because
The entire nucleotide sequence of the mutated gene 6 was determined
from the 35 lytic clones. Four of them had a premature stop codon. Most
of the mutants had more than three amino acid changes, and only five
carried double or triple mutations as shown in Fig.
5. Amino acid sequence comparison with
the p6R6A protein (p6m) showed that the mutations were mainly clustered
in two regions: N-terminal, around position 8 (region I,
Fig. 5), like those in p6m8 and p6m22 mutant proteins, and a central
region around position 44 (region II, Fig. 5), like p6m23
and p6m41 mutant proteins. Mutant protein p6m94 carried a single
mutation in each region.
Residues Involved in Self-association of Protein p6 in
Vitro--
The non-random distribution of in vivo selected
mutants strongly suggested the involvement of regions I and II in
protein p6 self-interaction. To assess directly the involvement of
individual residues in protein-protein interaction, we designed
site-directed mutations on positions 7, 8, 43, and 44, where wt
residues were replaced by those found in mutants selected in
vivo (Fig. 5), namely E7V, I8T, Q43R, and A44V. The site-directed
mutagenesis was performed by PCR on plasmid pPR55w6, encoding wt gene 6 (23). The mutated genes were cloned into an expression vector under the
control of the bacteriophage
These results prompted us to further study the self-interaction
capability of the protein p6 mutants by analytical ultracentrifugation. Sedimentation equilibrium studies had shown that protein p6, in the
1-100 µM range, is in a monomer-dimer equilibrium with a
dimerization constant (K2) of 2 × 105 M
Protein p6 forms a nucleoprotein complex with phage Ø29 DNA terminal
fragments, in which the DNA wraps around a multimeric protein core
(39). The formation of the complex can be detected by a characteristic
DNase I footprint pattern, in which strong hypersensitivities, with a
periodicity of 24 bp, are located in between protected regions (36). As
shown in Fig. 9, protein p6A44V required
a 2.5-fold higher protein amount (0.5 µg) than protein p6wt (0.2 µg) to form the complex; this may reflect the reduced capacity to
form dimers of p6A44V mutant. In addition, we can observe that the
digestion pattern formed with p6A44V is slightly different than that
observed with p6wt. As it could be expected from the previous results,
p6I8T mutant protein failed to bind DNA even at a 20-fold higher
protein concentration than that of the p6wt (Fig. 9).
Protein p6 of B. subtilis phage Ø29 binds DNA forming
a multimeric nucleoprotein complex (39) that is required for activation of Ø29 DNA initiation of replication (37, 38), repression of
transcription from early C2 promoter (13, 16), and regulation of viral
switch between early and late transcription (17). Protein p6 in
solution forms elongated oligomers from preformed dimers, at the
in vivo estimated protein concentration (19). Oligomeric structures have been proposed to provide the scaffold on which the DNA
folds into the appropriate configuration. Protein p6 binding to DNA
requires multiple protein-DNA and protein-protein interactions. Thus,
failure to bind DNA of N-terminal deletion mutants of 5 or 13 amino
acids in protein p6 (29), can be explained by their impaired or lost
capacity, respectively, in dimer formation.
We have looked for other regions involved in protein p6
self-association by using an in vivo system based on the
immunity of cells expressing The involvement of region II in dimer formation is shown by p6A44V
mutant protein, which has a slightly reduced capacity to form dimers.
In agreement with this, DNase I footprinting (Fig. 9) shows that p6A44V
has a DNA binding affinity lower than that of the p6wt protein and an
impaired activation of Ø29 DNA initiation of replication.
The involvement in dimer formation of region I (see Fig. 5) was
expected from the results obtained with protein p6 N-terminal deletion
mutants. The p6I8T mutant protein failed to activate the Ø29 DNA
initiation of replication, DNA binding was not detected, and dimer
formation was reduced at least 10-fold. Mutant p6 proteins are folded,
as shown in Fig. 10, where the circular
dichroism spectra of the wt and mutant p6 proteins do not show
significant differences in their secondary structure. Altogether, these
results suggest that Ile8 is involved in the
self-interaction of protein p6.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
-D-thiogalactopyranoside
(IPTG) and ampicillin were acquired from Sigma. Restriction enzymes
(HindIII, EcoRV, BamHI, and
DraI), Vent polymerase, and T4-polynucleotide kinase were obtained from New England BioLabs, Taq polymerase from
Perkin-Elmer, oligonucleotides from Genset Oligos, dNTP from Amersham
Pharmacia Biotech, [
-32P]dATP (3000 Ci/mmol) and
[
-32P]ATP (3000 Ci/mmol) from Amersham International
plc. Glutaraldehyde was purchased from Serva.
cI Repressor Fusions--
The plasmid
pBF21, containing the
cI gene under the control
of a tandem lacUV5 promoter-operator region (10), was
digested with HindIII and EcoRV to remove the
cI gene fragment encoding the oligomerization domain (OD)
(Fig. 1). Plasmids p
cIp6 and p
cIp6m were made by a polymerase chain reaction (PCR) step cloning procedure. Wild-type (wt) gene 6, cloned in plasmid pPR55w6 (23), and
mutant gene 6R6A, from plasmid pPR55R6A (23), were obtained by
PCR by using primers designed to introduce HindIII and
EcoRV restriction sites
5'-GAAAGTGGGAAAGCTTTATGGCAA-3' and
5'-CCTTCTCTTGTGATATCATCATTCAGC-3', respectively. PCRs
were carried out with 1 µM oligonucleotides, 0.2 µg of
pPR55w6 or pPR55R6A as templates, 100 µM dNTP, and 2 units of Vent polymerase on its reaction buffer. PCR fragments were
cloned into digested pBF21, to generate plasmids p
cIp6 and p
cIp6m, containing chimeric genes encoding for the DNA binding domain of the cI repressor, cI(DBD), fused to those encoding for p6wt
protein or to mutant protein p6R6A, respectively (Fig. 1). The wt and
mutant gene 6 were sequenced from the plasmids.

View larger version (17K):
[in a new window]
Fig. 1.
Schematic representation of the plasmids
used. Plasmid pBF21 encodes the
cI repressor containing both
the DNA binding domain (DBD) and the oligomerization domain
(OD); plasmid pBF22 encodes only the
cI(DBD), lacking
the cI(OD) (
cI); plasmid p
cIp6 encodes the
cI fused to the p6wt protein. Plasmid p
cIp6m encodes the
cI
fused to the p6R6A mutant protein. Mutation R6A abolished the DNA
binding ability of protein p6. In all cases these genes are under the
control of tandem lacUV5 promoters (lacP). The
relative positions of HindIII (H) and
EcoRV (EV) restriction sites are indicated. The
plasmids contained ampicillin resistance gene
(amp).
cIp6m. The
oligonucleotides used generated HindIII and EcoRV
restriction sites (5'-GGCTCCAAGCCAAGCTTTATG-3' and
5'-CGGAATGGACGATATCATCA-3'). To obtain random mutations,
PCR was carried out under two different conditions: one had limited
dATP (20 µM) and the other had additionally 0.5 mM MnCl2 (24, 25). Thus, the reactions
contained 1 µM oligonucleotides; 0.2 µg of plasmid;
1.25 mM MgCl2; 5 units of Taq
polymerase; 100 µM each of dCTP, dGTP, and dTTP; and 20 µM dATP, in the absence or in the presence of 0.5 mM MnCl2 in Taq polymerase buffer.
The mutated fragments were digested with HindIII and
EcoRV and cloned into plasmid pBF21 digested with the same enzymes. E. coli 71-18 lacIq cells
(26) were transformed with these constructions and tested for
phage
development as described below. The mutated gene 6 was sequenced in
those clones showing a lytic phenotype.
Phage Development--
E. coli 71-18 lacIq cells transformed with plasmid pBF21 or
the derivatives described above, were grown at 37 °C up to an
optical density of 0.6 at 620 nm in LB medium containing ampicillin
(100 µg/ml). The production of chimeric proteins was induced by
addition of 250 µl of 100 mM IPTG to 0.4 ml of culture.
After induction, cells were infected with
146 hypervirulent phage
(27), essentially as described (10). After 5-min incubation, 5 ml of LB
medium containing ampicillin (100 µg/ml) was added to the infected
cultures, which were further incubated at 37 °C. At the indicated
times, 0.4-ml aliquots were centrifuged and 150 µl of supernatant was mixed with 30 µl of chloroform. The number of plaques forming units
per milliliter in each supernatant was determined using E. coli 71-18 lacIq as the recipient strain.
PL promoter. The
lysogen E. coli K-12
H1
trp encoding the thermosensitive cI857 repressor
(28) was electroporated with the recombinant plasmids to obtain a
library of random mutants. The mutations were determined by sequencing
the corresponding gene 6 in selected clones from the library.
H1
trp cells transformed with the
recombinant plasmids pMJn
5 and pMJn
13 (29) and pMJc
14 and pMJc
16 (30) were induced for 1 h at 42 °C. After
centrifugation, 20 g of cells was ground with alumina and
extracted with buffer A (50 mM Tris-HCl, pH 7.5, 1 mM EDTA, 7 mM
-mercaptoethanol, 5%
glycerol) with 0.5 M NaCl. Alumina and cell debris were
removed by centrifugation. Polyethyleneimine (PEI) was added to the
supernatant up to 0.25%, after adjusting absorbance at 260 nm to 120 units/ml, and centrifuged for 10 min at 10,000 × g to
remove DNA. The supernatant was made 0.35 M NaCl with
buffer A; deletion mutant proteins were recovered in the pellet after
centrifugation as above. To eliminate PEI, pellets were resuspended in
buffer A containing 0.4 M NaCl, and the proteins were
precipitated with ammonium sulfate up to 70% saturation. Pellets
containing N-terminal deletion mutants, p6N
5 and p6N
13, were
resuspended in buffer A and applied to a DEAE-cellulose column, whereas
those containing C-terminal deletion mutants, p6C
14 and p6C
16,
were applied to a phosphocellulose column. They were eluted with salt
concentrations ranging from 75 to 200 mM NaCl. The mutant
proteins were further subjected to heparin-agarose chromatography and
eluted at salt concentrations from 50 to 350 mM NaCl. Minor
contaminants were eliminated using Centricon-50 from Amicon; after this
step the purity of the mutant proteins was estimated to be 95% by
SDS-polyacrylamide gel electrophoresis (PAGE) followed by Coomassie
Blue staining.
H1
trp cells, transformed with plasmids
encoding protein p6 site-directed mutants, were induced for 2 h at
42 °C. After centrifugation, 6-8 g of cells was ground with
alumina, and the DNA was removed as described above. The mutant
proteins were extracted from the PEI pellet by washing with 1 M NaCl buffer A and precipitated with ammonium sulfate to
up to 70% saturation. Pellets containing mutant proteins were resuspended in buffer A and applied to a phosphocellulose column, except p6I8T, which was applied to a DEAE-cellulose column. The different protein p6 mutants were eluted with buffer A containing NaCl
concentrations from 75 to 200 mM. Minor contaminants were eliminated by 15-30% glycerol gradient centrifugation. After this step all protein p6 single mutants were more than 90% homogeneous as
estimated by SDS-PAGE followed by Coomassie Blue staining.
-32P]dATP; 0.3 µg of phage Ø29 terminal
protein-DNA complex, purified as described (31); 20 ng of terminal
protein; 20 ng of Ø29 DNA polymerase; and the indicated amounts of
either protein p6wt or protein p6 mutants. After incubation for 15 min
at 15 °C, the reaction was stopped by adding up to 10 mM
EDTA and 0.1% SDS. The samples were filtered through Sephadex G-50
spin columns in the presence of 0.1% SDS. The initiation complex
formed was analyzed by SDS-PAGE as described (31). Quantification was
performed by using a Fuji BAS-1500 image analyzer.
-32P]ATP using T4 polynucleotide kinase to obtain the
Ø29 DNA terminal fragment internally labeled. The PCR product was
digested with DraI to restore the Ø29 DNA terminal end.
DNase I digestion was carried out for 5 min at 15 °C in 25 µl of a
solution containing 10 mM MgCl2. The reaction
was stopped by addition of EDTA, pH 8.0, up to 20 mM final
concentration. DNA was precipitated with ethanol in the presence of RNA
carrier (0.25 mg/ml) and then subjected to denaturing electrophoresis
in 6% (w/v) acrylamide gel.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
5 and p6N
13, respectively) were not able to
interact with a Ø29 DNA terminal fragment as detected by DNase I
footprinting (29). Because DNA binding is highly
cooperative1 and requires the formation of large oligomers,
the lack of DNA binding could be due to a deficiency in protein p6
self-association; therefore, we tested by glutaraldehyde cross-linking
the capability of both deletion mutants to self-associate. Fig.
2 shows that dimer formation was highly
impaired in the p6N
5 mutant, being about 10% that of the p6wt
protein. In addition, dimers were not detected with the p6N
13 mutant
(not shown). On the other hand, a 14-amino acid C-terminal deletion
mutant of protein p6 (p6C
14) bound DNA 2-fold better than the p6wt
protein (30). Two C-terminal deletion mutants of 14 and 16 amino acids
(p6C
14 and p6C
16, respectively) were tested for dimer formation
by glutaraldehyde cross-linking. As Fig. 2 shows, the ability of dimer
formation in the p6C
16 mutant protein was about 2-fold that of
the p6wt protein; a similar result was obtained with the mutant protein p6C
14 (not shown). Therefore, the observed DNA binding properties of
p6N
5, p6N
13, p6C
14, and p6C
16 mutants could be explained by
their self-association capacities. These results indicate that the
N-terminal region of protein p6 is required for glutaraldehyde cross-linking, suggesting that this region is involved in dimer formation; however, glutaraldehyde cross-linking is favored when the
C-terminal region is removed, suggesting that this region impairs dimer
formation.

View larger version (54K):
[in a new window]
Fig. 2.
Dimer formation of protein p6wt and deletion
mutants. wt protein p6, the 5-amino acid N-terminal deletion
mutant p6N
5, and the 16-amino acid C-terminal deletion mutant
p6C
16 were cross-linked with glutaraldehyde as described under
"Experimental Procedures" and run in SDS-Tricine-PAGE along with
untreated samples. The mobilities of molecular mass standards are
indicated.
cI repressor as a reporter gene for
dimerization (10). Phage
cI repressor is a two-domain protein that
binds DNA as a dimer; the N-terminal part is the DNA binding domain,
cI(DBD), whereas the C-terminal one is the oligomerization domain,
cI(OD), which is required for an efficient binding to the operator.
Thus, E. coli cells expressing only cI(DBD) (
cI) were
sensitive to hypervirulent phage
146 infection, whereas those with
intact cI were immune. Replacement of the cI(OD) by another protein
provides a self-interaction assay for that protein.
phage cI
repressor under the control of the lac promoter, to
construct p
cIp6 plasmid encoding a fusion protein containing the
cI and the protein p6wt (Fig. 1). The dimerization capacity of
protein p6 was assayed by determining the development of infecting
146 phage in E. coli cells harboring the p
cIp6 plasmid
upon induction with IPTG. Cells expressing the
cIp6 fusion protein
were not immune to
146 infection (Fig.
3), behaving as the control cells expressing
cI. This result was unexpected, because protein p6 self-interacts in vitro. The expression of
cIp6 fusion
protein was confirmed by Western blot analysis with protein p6
antiserum (not shown). An explanation for the lytic phenotype could be
that the non sequence-specific DNA binding ability of protein p6 (37) prevented the binding of the
cI to the operators. To avoid this, plasmid p
cIp6m (see Fig. 1) was constructed, expressing a fusion containing the
cI and the protein p6 mutant defective in DNA binding
p6R6A (38). Cells harboring the plasmid p
cIp6m showed, upon
induction, a time course development of
146 phage similar to that of
the control cells expressing intact
cI repressor. In these
cases, the number of pfu/ml was about 104-fold lower than
that obtained in cells expressing
cI (Fig. 3). Therefore, we can
conclude that the mutant protein p6R6A functionally replaces the cI(OD)
allowing dimerization of the
cI. This strongly suggests that protein
p6 self-associates in vivo.

View larger version (16K):
[in a new window]
Fig. 3.
In vivo dimerization assay for
protein p6. Phage
146 development, represented as the number of
pfu/ml produced at the indicated times after infection, in cells
expressing
cI repressor wt (cI),
cI(DBD)
(
cI),
cI-p6wt fusion protein
(
cIp6), and
cI-p6R6A mutant fusion protein
(
cIp6m).
cIp6m fusion protein confers immunity to
146 infection, random mutagenesis was performed on mutant gene 6R6A
contained in plasmid p
cIp6m. The PCR products were cloned as above,
under the control of the lac promoter, in-frame to the
cI(DBD). Therefore, chimeric proteins consisting of
cI and random
mutants of protein p6R6A were expressed. Individual colonies were
tested for
phage development as above, and clones showing a lytic
phenotype were selected as candidates defective in protein p6
self-interaction. From 200 individual clones, 35 showed a lytic
phenotype. Fig. 4 shows the development
of
146 phage in selected lytic clones, which was about
104-fold higher than that of cells expressing
cIp6m. The
expression of the fusion proteins was assessed by Western
immunoblotting analysis using antiserum against protein p6 (not
shown).

View larger version (19K):
[in a new window]
Fig. 4.
In vivo dimerization assay for
random mutants of protein p6R6A. Time-course development (pfu/ml)
of
146 phage after infection of E. coli 71-18 lacIq cells harboring plasmids expressing
cIp6m8,
cIp6m22,
cIp6m23,
cIp6m41, or
cIp6m94 fusion
proteins. Cells expressing the
cIp6m fusion protein were used as a
control.
![]()
View larger version (8K):
[in a new window]
Fig. 5.
Amino acid sequence of random mutant p6
proteins. Amino acid sequence of protein p6R6A mutant (p6m) and
the in vivo selected mutants shown in Fig. 4. Only
differences with p6R6A protein are indicated. I and
II indicate the clusters of point mutations found in the
in vivo selected random mutants. Basic and acidic regions of
the proteins are pointed out.
PL promoter. Mutants were
overproduced and purified up to at least 90% homogeneity. Protein p6
mutants were tested for activation of initiation of phage Ø29 DNA
replication in an in vitro assay with purified proteins
(14). Fig. 6 shows the results obtained
with the mutant proteins p6E7V, p6I8T, p6Q43R, and p6A44V. Although the
mutants p6E7V and p6Q43R showed an activation similar to that of the
p6wt protein, the p6A44V mutant protein exhibited about a 6-fold
reduced capacity to activate the initiation reaction. No activation was
detected by the p6I8T mutant. The deficiency observed in the activation
of the initiation reaction in p6A44V and p6I8T mutant proteins could be
due to an impaired self-association and/or DNA binding. Because we have
selected these mutants in an in vivo self-association assay,
we first studied the dimerization properties of the protein p6 mutants.
The effect of the p6A44V and p6I8T mutations in self-interaction was
tested, as a first approach, by glutaraldehyde cross-linking. The
amount of dimers formed by the p6A44V and p6I8T mutant proteins was
50% and 7%, respectively, of that found in the p6wt protein (Fig. 7).

View larger version (51K):
[in a new window]
Fig. 6.
Activation of initiation of Ø29 DNA
replication by wt protein p6 and site-directed mutants. Formation
of the initiation complex (TP-dAMP) in the absence or in the presence
of the indicated amount of wt protein p6 or site-directed mutants
p6E7V, p6I8T, p6Q43R, or p6A44V.

View larger version (20K):
[in a new window]
Fig. 7.
Dimer formation of protein p6wt and
site-directed mutants. Glutaraldehyde cross-linking of protein
p6wt and single mutants p6A44V and p6I8T. Proteins were cross-linked as
described under "Experimental Procedures" and run in
SDS-Tricine-PAGE, along with untreated samples. The mobilities of
molecular mass standards are indicated.
1 that shifts to higher
association states at higher protein concentration (19). Fig.
8 shows that, at 100 µM and
4 °C, the Mw,a) of protein p6wt was
25,400, whereas those of p6A44V and p6I8T mutant proteins were
20,600 and 15,500, respectively, the latter being close to the
theoretical value for the wt protein p6 monomer (11,900). Assuming that
mutant proteins have the same self-association behavior as p6wt (19),
the dimerization constant of p6A44V is slightly lower than that of the
p6wt3; however, the
K2 of p6I8T is, at least, 10-fold lower than
that of the p6wt protein.3 Therefore, we can conclude that
A44V mutation slightly affects protein dimerization, which is almost
abolished by the mutation I8T.

View larger version (28K):
[in a new window]
Fig. 8.
Sedimentation equilibrium analysis of protein
p6wt and site-directed mutants. Sedimentation equilibrium profile
of 100 µM protein p6wt (
), p6A44V (
), and p6I8T
(
) taken at 25,000 rpm and 4 °C as described under
"Experimental Procedures." The symbols represent the
experimental data, and the solid lines show the best fit
functions for a single solute, at sedimentation equilibrium. The
Mw,a for each protein is indicated.

View larger version (60K):
[in a new window]
Fig. 9.
DNA binding of protein p6wt and site-directed
mutants. The 259-bp left terminal fragment of Ø29 DNA was used to
perform DNase I footprinting of p6wt and site-directed mutants p6A44V
and p6I8T. The protein amount used as well as the nucleotide positions
from the left Ø29 genome end are indicated.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
cI repressor to
phage infection.
If the
cI(OD) is removed, immunity is lost and the infecting phage can develop lytic cycle. Thus, replacement of the cI(OD) by other protein provides a self-interaction test for this protein. When
cI
was fused to the gene encoding p6R6A mutant protein, immunity was
achieved, suggesting that the protein self-interacts in
vivo. Thus, random mutants of protein p6R6A, obtained by
degenerated PCR, were tested for self-association. Although the
proteins contained multiple mutations, they were not randomly arranged,
but mainly clustered in two regions located at the N-terminal and the
central region of protein p6 (regions I and II in
Fig. 5). Therefore, single site-directed mutants of protein p6wt
corresponding to some of those found in vivo were
constructed and assayed in vitro. Taking into account that
the in vivo selected mutant proteins p6m23 and p6m41 (Fig.
5) share the Q43R mutation, we would expect an involvement of
Gln43 in protein p6 self-interaction. However, this was not
confirmed by in vitro experiments with the corresponding
site-directed mutant. The mutant protein p6Q43R did not show any
significant difference with the wt protein in the activation of Ø29
DNA initiation of replication or glutaraldehyde cross-linking. A
possible explanation for this result could be that the in
vivo assay is more restrictive. In addition, the single mutation
may not be enough to show an impaired dimerization, and additional
changes might be required, like those found in the in vivo
selected mutants.

View larger version (15K):
[in a new window]
Fig. 10.
Circular dichroism spectra of the wild-type
and single mutant proteins. The spectrum of the p6wt protein
(
), p6A44V (
), and p6I8T (
) after base line correction.
It has been reported that a C-terminal, 14-amino acid truncated p6 protein has a DNA binding activity 2-fold higher than that of the p6wt protein (30). We have now shown that this truncated protein has increased its capacity to form dimers. Protein p6 has a very acidic C terminus, where 10 out of 19 residues are either Asp or Glu (see Fig. 5). Therefore, it seems likely that the C-terminal acidic region modulates protein p6 self-association, interacting with a basic region. There is a cluster of basic residues overlapping region II (see Fig. 5), although interaction with region I, which also contains basic residues, cannot be ruled out. This interaction could contribute to the dynamic nature of the protein p6 binding to DNA (20).
In summary, we have found two regions involved in vivo in
self-association of phage Ø29 protein p6, the N-terminal and a central region. Site-directed mutation A44V, located at the central region, impairs the protein p6 self-association. The N-terminal mutation I8T
has a more drastic effect and completely abolished dimer formation.
| |
ACKNOWLEDGEMENTS |
|---|
We are very grateful to Drs. R. Spurio and
C. O. Gualerzi for kindly providing us plasmids pBF21 and pBF22,
146 phage, and E. coli strain 71-18 lacIq; J. Fernández and Dr. G. Rivas for
their help with the analytical ultracentrifugation experiments; Dr. R. Giraldo for help in the circular dichroism experiments; J. M. Lázaro and L. Villar for the purification of wt and site-directed
p6 mutant proteins; and Dr. A. Bravo for helpful discussions.
| |
FOOTNOTES |
|---|
* This work was supported by Research Grant 5R01 GM27242-20 from the National Institutes of Health, by Grant PB98-0645 from Dirección General de Investigación Científica y Técnica, by Grant ERBFMX CT97 0125 from the European Union, and by an institutional grant from Fundación Ramón Areces.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Recipient of a predoctoral fellowship from Comunidad
Autónoma de Madrid.
§ To whom correspondence should be addressed: Tel.: 34-91-3978435; Fax: 34-91-3974799; E-mail: msalas@cbm.uam.es.
Published, JBC Papers in Press, May 26, 2000, DOI 10.1074/jbc.M002739200
1 A. M. Abril, unpublished results.
3 G. Rivas, personal communication.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
bp, base pairs(s);
OD, oligomerization domain;
DBD, DNA binding domain;
wt, wild-type;
pfu, plaque-forming units;
PEI, polyethyleneimine;
Mw, a,
apparent weight-average molecular weight;
IPTG, isopropyl
-D-thiogalactopyranoside;
PAGE, polyacrylamide gel
electrophoresis.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Rouvière-Yaniv, J., and Kjeldgaard, N. O. (1979) FEBS Lett. 106, 297-300 |
| 2. | Claret, L., and Rouvière-Yaniv, J. (1997) J. Mol. Biol. 273, 93-104 |
| 3. | Miller, H. I. (1984) Cold Spring Harbor Symp. Quant. Biol. 43, 1121-1126 |
| 4. | Flamm, E. L., and Weisberg, R. A. (1985) J. Mol. Biol. 183, 117-128 |
| 5. | Johnson, R. C., Ball, C. A., Pfeffer, D., and Simon, M. I. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 3484-3488 |
| 6. | Koch, C., Vandekerckhove, J., and Kahmann, R. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 4237-4241 |
| 7. | Ceschini, S., Lupidi, G., Coletta, M., Pon, C. L., Fioretti, E., and Angeletti, M. (2000) J. Biol. Chem. 275, 729-734 |
| 8. | Ueguchi, C., Seto, C., Suzuki, T., and Mizuno, T. (1997) J. Mol. Biol. 274, 145-151 |
| 9. | Williams, R. M., Rimsky, S., and Buc, H. (1996) J. Bacteriol. 178, 4335-4343 |
| 10. | Spurio, R., Falconi, M., Brandi, A., Pon, C. L., and Gualerzi, C. O. (1997) EMBO J. 16, 1795-1805 |
| 11. | Talavera, A., Salas, M., and Viñuela, E. (1972) Eur. J. Biochem. 31, 367-371 |
| 12. | Carrascosa, J. L., Camacho, A., Moreno, F., Jiménez, F., Mellado, R. P., Viñuela, E., and Salas, M. (1976) Eur. J. Biochem. 66, 229-241 |
| 13. | Whiteley, H. R., Ramey, W. D., Spiegelman, G. B., and Holder, R. D. (1986) Virology 155, 392-401 |
| 14. | Pastrana, R., Lázaro, J. M., Blanco, L., García, J. A., Méndez, E., and Salas, M. (1985) Nucleic Acids Res. 13, 3083-3100 |
| 15. | Blanco, L., Gutiérrez, J., Lázaro, J. M., Bernad, A., and Salas, M. (1986) Nucleic Acids Res. 14, 4923-4937 |
| 16. | Barthelemy, I., Mellado, R. P., and Salas, M. (1989) J. Virol. 63, 460-462 |
| 17. | Elías-Arnanz, M., and Salas, M. (1999) Genes Dev. 13, 2502-2513 |
| 18. | Serrano, M., Gutiérrez, C., Salas, M., and Hermoso, J. M. (1993) J. Mol. Biol. 230, 248-259 |
| 19. | Abril, A. M., Salas, M., Andreu, J. M., Hermoso, J. M., and Rivas, G. (1997) Biochemistry 36, 11901-11908 |
| 20. | Gutiérrez, C., Freire, R., Salas, M., and Hermoso, J. M. (1994) EMBO J. 13, 269-276 |
| 21. | Azam, T. A., Iwata, A., Nishimura, A., Ueda, S., and Ishihama, A. (1999) J. Bacteriol. 181, 6361-6370 |
| 22. | Abril, A. M., Marco, S., Carrascosa, J. L., Salas, M., and Hermoso, J. M. (1999) J. Mol. Biol. 292, 581-588 |
| 23. | Bravo, A., Hermoso, J. M., and Salas, M. (1994) Mol. Gen. Genet. 245, 529-536 |
| 24. | Arcangioli, B., Ghazvini, M., and Ribes, V. (1994) Nucleic Acids Res. 22, 2930-2937 |
| 25. | Leung, D. W., Chen, E., and Goeddel, D. V. (1989) Technique 1, 11-15 |
| 26. | Yanisch-Perron, C., Vieira, J., and Messing, J. (1985) Gene 33, 103-119 |
| 27. | Bailone, A., and Devoret, R. (1978) Virology 84, 547-550 |
| 28. | Remaut, E., Stanssens, P., and Fiers, W. (1981) Gene 15, 81-93 |
| 29. | Otero, M. J., Lázaro, J. M., and Salas, M. (1990) Gene 95, 25-30 |
| 30. | Otero, M. J., and Salas, M. (1989) Nucleic Acids Res. 17, 4567-4577 |
| 31. | Peñalva, M. A., and Salas, M. (1982) Proc. Natl. Acad. Sci. U. S. A. 79, 5522-5526 |
| 32. | Balzer, D., Ziegelin, G., Pansegrau, W., Kruft, V., and Lanka, E. (1992) Nucleic Acids Res. 20, 1851-1858 |
| 33. | Schagger, H., and Jagow, G. (1987) Anal. Biochem. 166, 368-379 |
| 34. | Minton, A. P. (1994) in Modern Analytical Ultracentrifugation (Shuster, T. M. , and Laue, T. M., eds) , pp. 81-93, Birkhauser, Boston, MA |
| 35. | Murray, C. L., and Rabinowitz, J. C. (1982) J. Biol. Chem. 257, 1053-1062 |
| 36. | Prieto, I., Serrano, M., Lázaro, J. M., Salas, M., and Hermoso, J. M. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 314-318 |
| 37. | Serrano, M., Gutiérrez, J., Prieto, I., Hermoso, J. M., and Salas, M. (1989) EMBO J. 8, 1879-1885 |
| 38. | Freire, R., Salas, M., and Hermoso, J. M. (1994) EMBO J. 13, 4353-4360 |
| 39. | Serrano, M., Salas, M., and Hermoso, J. M. (1990) Science 248, 1012-1016 |
This article has been cited by other articles:
![]() |
W. J. J. Meijer, J. A. Horcajadas, and M. Salas {phi}29 Family of Phages Microbiol. Mol. Biol. Rev., June 1, 2001; 65(2): 261 - 287. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals |